Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Equities researchers at StockNews.com assumed coverage on shares of VolitionRx (NYSE:VNRX – Get Free Report) in a research report issued on Thursday. The brokerage set a “sell” rating on the stock.

Ukraine war latest: Trump says US could run Ukraine's nuclear plants - as Moscow and Kyiv launch drone strikes in hours after Zelenskyy call Donald Trump suggested the US could run Ukraine's ...